NEW YORK (

TheStreet

) -- The ex-dividend date for

Pharmaceutical Product Development

(Nasdaq:

PPDI

) is Monday, June 13, 2011. Owners of shares as of market close today will be eligible for a dividend of 15 cents per share. At a price of $26.79 as of 9:32 a.m. ET, the dividend yield is 2.2%.

The average volume for Pharmaceutical Product Development has been 771,000 shares per day over the past 30 days. Pharmaceutical Product Development has a market cap of $3 billion and is part of the

health care

sector and

health services

industry. Shares are down 1% year to date as of the close of trading on Thursday.

Pharmaceutical Product Development, Inc., a contract research organization, provides drug discovery, development, and lifecycle management services. It operates in two segments, Development and Laboratory Services. The company has a P/E ratio of 22.1, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

  • Practice your dividend trading strategies and win cash in our stock game.

TheStreet Ratings rates Pharmaceutical Product Development as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, increase in net income and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full

Pharmaceutical Product Development Ratings Report

.

See our

dividend calendar

or

top-yielding stocks list

.

null